Insider Transaction Report for Patrick A. Mayes

Patrick A. Mayes, EVP & Chief Scientific Officer of INCYTE CORP, reported a series of transactions on July 16, 2026. Mayes acquired 5,916 shares of Common Stock, acquired 14,790 Performance Shares, and was granted 25,538 Employee Stock Options. The Performance Shares may result in up to 200% of the stated shares based on relative total shareholder return over a three-year period, vesting on the third anniversary of the grant date. The stock options vest in installments over three years, with the first tranche vesting after one year. All transactions were marked as direct ownership with a transaction price of $0.00. Post-transaction, Mayes holds 63,628 shares of Common Stock, 14,790 Performance Shares, and 25,538 Employee Stock Options.